Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniela Fischer
Daniela Fischer
Boehringer Ingelheim
Exemestane
Paclitaxel
mTORC1
Medicine
Pathology
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.
2020
Cancers
Filippo de Braud
Jean-Pascal Machiels
Daniela Boggiani
Sylvie Rottey
Matteo Duca
Marie Laruelle
Stefania Salvagni
Silvia Damian
Lore Lapeire
Marcello Tiseo
Alexandre Dermine
Mahmoud Ould-Kaci
Juergen Braunger
Juliane Rascher
Daniela Fischer
Josef Hoefler
Gabriella L. Mariani
Sara Cresta
Show All
Source
Cite
Save
Citations (1)
Phase I study of mTORC1/2 inhibitor BI 860585 as single agent or with exemestane or paclitaxel in patients with advanced solid tumors.
2016
Journal of Clinical Oncology
Filippo de Braud
Jean-Pascal Machiels
Marcello Tiseo
Sylvie Rottey
Matteo Duca
Marie Laruelle
Stefania Salvagni
Lore Lapeire
Laura Manfreda
Céline Veau
Daniela Fischer
Mahmoud Ould-Kaci
Show All
Source
Cite
Save
Citations (1)
1